These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 29442039

  • 1. Design and production of methyl jasmonate nanoemulsions using experimental design technique and evaluation of its anti-cancer efficacy.
    Habibi K, Sepehri H, Delphi L, Mirjalili MH, Rafati H.
    Pharmazie; 2017 Nov 01; 72(11):652-662. PubMed ID: 29442039
    [Abstract] [Full Text] [Related]

  • 2. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
    Wang Y, Xiang W, Wang M, Huang T, Xiao X, Wang L, Tao D, Dong L, Zeng F, Jiang G.
    Br J Pharmacol; 2014 Feb 01; 171(3):618-35. PubMed ID: 24490857
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells.
    Jeoung NH, Jo AL, Park HS.
    Biochem Biophys Res Commun; 2021 Jun 18; 558():22-28. PubMed ID: 33894674
    [Abstract] [Full Text] [Related]

  • 4. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.
    Yeruva L, Hall C, Elegbede JA, Carper SW.
    Anticancer Drugs; 2010 Jan 18; 21(1):1-9. PubMed ID: 19820395
    [Abstract] [Full Text] [Related]

  • 5. Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells.
    Yeruva L, Pierre KJ, Bathina M, Elegbede A, Carper SW.
    Cancer Invest; 2008 Nov 18; 26(9):890-9. PubMed ID: 18798057
    [Abstract] [Full Text] [Related]

  • 6. Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells.
    Klippel S, Jakubikova J, Delmore J, Ooi M, McMillin D, Kastritis E, Laubach J, Richardson PG, Anderson KC, Mitsiades CS.
    Br J Haematol; 2012 Nov 18; 159(3):340-51. PubMed ID: 22970818
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y.
    Int J Pharm; 2012 Jul 01; 430(1-2):238-46. PubMed ID: 22465546
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines.
    Sucu BO, Ipek OS, Kurtulus SO, Yazici BE, Karakas N, Guzel M.
    Bioorg Chem; 2019 Oct 01; 91():103146. PubMed ID: 31377389
    [Abstract] [Full Text] [Related]

  • 11. Isolation of the four methyl jasmonate stereoisomers and their effects on selected chiral volatile compounds in red raspberries.
    Flores G, Blanch GP, Ruiz del Castillo ML.
    Food Chem; 2013 Dec 01; 141(3):2982-7. PubMed ID: 23871049
    [Abstract] [Full Text] [Related]

  • 12. Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells.
    Yeruva L, Elegbede JA, Carper SW.
    Anticancer Drugs; 2008 Sep 01; 19(8):766-76. PubMed ID: 18690087
    [Abstract] [Full Text] [Related]

  • 13. Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice.
    Annafi OS, Aluko OM, Eduviere AT, Omorogbe O, Umukoro S.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep 01; 390(9):883-892. PubMed ID: 28612111
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory and membrane stabilizing properties of methyl jasmonate in rats.
    Umukoro S, Alabi AO, Eduviere AT, Ajayi AM, Oluwole OG.
    Chin J Nat Med; 2017 Mar 01; 15(3):202-209. PubMed ID: 28411688
    [Abstract] [Full Text] [Related]

  • 15. Role of purinergic signaling pathways in the adaptogenic-like activity of methyl jasmonate in rats exposed to unpredictable chronic mild stress.
    Aluko OM, Umukoro S.
    Drug Metab Pers Ther; 2020 Jul 22; 35(3):. PubMed ID: 32975203
    [Abstract] [Full Text] [Related]

  • 16. Methyl Jasmonate Ameliorates Unpredictable Chronic Mild Stress-Induced Behavioral and Biochemical Alterations in Mouse Brain.
    Adebesin A, Ajayi AM, Olonode EO, Omorogbe O, Umukoro S.
    Drug Dev Res; 2017 Dec 22; 78(8):381-389. PubMed ID: 28921671
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of biocompatible isotropic and anisotropic oil-in-water colloidal dispersions as a new delivery system for methyl dihydrojasmonate antitumor drug.
    da Silva GB, Scarpa MV, Rossanezi G, do Egito ES, de Oliveira AG.
    Int J Nanomedicine; 2014 Dec 22; 9():867-76. PubMed ID: 24596463
    [Abstract] [Full Text] [Related]

  • 18. Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma.
    Reischer D, Heyfets A, Shimony S, Nordenberg J, Kashman Y, Flescher E.
    Br J Pharmacol; 2007 Mar 22; 150(6):738-49. PubMed ID: 17293888
    [Abstract] [Full Text] [Related]

  • 19. Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line.
    Yousefi S, Darvishi P, Yousefi Z, Pourfathollah AA.
    J Bioenerg Biomembr; 2020 Apr 22; 52(2):103-111. PubMed ID: 31960257
    [Abstract] [Full Text] [Related]

  • 20. Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis.
    Ofer K, Gold D, Flescher E.
    Int J Parasitol; 2008 Jul 22; 38(8-9):959-68. PubMed ID: 18294640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.